Application

the risky proposition of extending the application of the EU Temporary Protection Directive beyond March 2025 – Go Health Pro

by
the risky proposition of extending the application of the EU Temporary Protection Directive beyond March 2025 – Go Health Pro

    Dr Meltem Ineli-Ciger, Associate Professor, Suleyman Demirel University Faculty of Law; Migration Policy Centre Associate, European University Institute   Photo credit: Falin, on Wikimedia Commons   What should follow once the deadline for the application of the Council Directive 2001/55/EC of 20 July 2001 (Temporary Protection Directive) to those fleeing the invasion of … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT DrugSorb-ATR Submission On October 1, 2024, CytoSorbents (NASDAQ:CTSO) announced the submission of its DrugSorb-ATR medical device De Novo marketing application to the U.S. Food and Drug Administration (FDA) on September 27, 2024. The goal of this product is to reduce the severity of perioperative … Read more

x